80 related articles for article (PubMed ID: 25795959)
1. Tissue effects of glutamine in rectal cancer patients treated with preoperative chemoradiotherapy.
Vidal-Casariego A; Hernando-Martín M; Calleja-Fernández A; Cano-Rodríguez I; Cordido F; Ballesteros-Pomar MD
Nutr Hosp; 2015 Apr; 31(4):1689-92. PubMed ID: 25795959
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.
Gunnlaugsson A; Kjellén E; Nilsson P; Bendahl PO; Willner J; Johnsson A
Acta Oncol; 2007; 46(7):937-44. PubMed ID: 17851844
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral glutamine during abdominal radiotherapy on chronic radiation enteritis: a randomized controlled trial.
Vidal-Casariego A; Calleja-Fernández A; Cano-Rodríguez I; Cordido F; Ballesteros-Pomar MD
Nutrition; 2015 Jan; 31(1):200-4. PubMed ID: 25466666
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial.
Vidal-Casariego A; Calleja-Fernández A; de Urbina-González JJ; Cano-Rodríguez I; Cordido F; Ballesteros-Pomar MD
JPEN J Parenter Enteral Nutr; 2014 Feb; 38(2):205-13. PubMed ID: 23471208
[TBL] [Abstract][Full Text] [Related]
6. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
[TBL] [Abstract][Full Text] [Related]
7. Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study.
Sakuyama N; Kojima M; Kawano S; Akimoto T; Saito N; Ito M; Ochiai A
Pathol Int; 2016 May; 66(5):273-80. PubMed ID: 27112135
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
9. Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study.
Rotovnik Kozjek N; Kompan L; Soeters P; Oblak I; Mlakar Mastnak D; Možina B; Zadnik V; Anderluh F; Velenik V
Clin Nutr; 2011 Oct; 30(5):567-70. PubMed ID: 21733605
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic role of glutamine in management of radiation enteritis: a meta-analysis of 13 randomized controlled trials.
Cao DD; Xu HL; Xu M; Qian XY; Yin ZC; Ge W
Oncotarget; 2017 May; 8(18):30595-30605. PubMed ID: 28427169
[TBL] [Abstract][Full Text] [Related]
11. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
12. [Our experiences of preoperative chemoradiotherapy for rectal cancer with invasion to adjacent organs].
Sato H; Maeda K; Hanai T; Koide Y; Matsuoka H; Katsuno H; Agata T; Noro T; Honda K; Shiota M; Ozeki S; Hatta K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2143-5. PubMed ID: 20037350
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
[TBL] [Abstract][Full Text] [Related]
14. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
15. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
[TBL] [Abstract][Full Text] [Related]
16. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
Brændengen M; Tveit KM; Bruheim K; Cvancarova M; Berglund Å; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1017-24. PubMed ID: 20932687
[TBL] [Abstract][Full Text] [Related]
17. Prediction of histologic regression on the basis of colonoscopic findings in patients with locally advanced middle and lower rectal cancer who receive preoperative chemoradiotherapy.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Okamura H; Machida T
Tokai J Exp Clin Med; 2011 Dec; 36(4):100-5. PubMed ID: 22167490
[TBL] [Abstract][Full Text] [Related]
18. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
